Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
利用CXCR2阻断靶向细胞异质性治疗耐药性前列腺癌
期刊:Science Translational Medicine
影响因子:14.6
doi:10.1126/scitranslmed.aax0428
Li, Yanjing; He, Yiping; Butler, William; Xu, Lingfan; Chang, Yan; Lei, Kefeng; Zhang, Hong; Zhou, Yinglu; Gao, Allen C; Zhang, Qingfu; Taylor, Daniel G; Cheng, Donghui; Farber-Katz, Suzette; Karam, Rachid; Landrith, Tyler; Li, Bing; Wu, Sitao; Hsuan, Vickie; Yang, Qing; Hu, Hailiang; Chen, Xufeng; Flowers, Melissa; McCall, Shannon J; Lee, John K; Smith, Bryan A; Park, Jung Wook; Goldstein, Andrew S; Witte, Owen N; Wang, Qianben; Rettig, Matthew B; Armstrong, Andrew J; Cheng, Qing; Huang, Jiaoti
CR2
肿瘤
肿瘤免疫
治疗耐药
CXCR2
细胞生物学
前列腺癌